Targeting the Beta-2-Adrenergic Receptor and the Risk of Developing Alzheimer’s Disease: A Retrospective Inception Cohort Study
Open Access
- 31 May 2022
- journal article
- research article
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 87 (3) , 1089-1101
Abstract
Background: Animal studies suggested that β2-Adrenergic receptors (β2AR) may be a potential target for the treatment of Alzheimer’s disease (AD). Objective: This retrospective inception cohort study aimed to assess the association between antagonists and agonists of the β2AR and the risk of starting treatment for AD in older adults. Methods: A retrospective inception cohort study was conducted among older adults who initiated either non-selective βAR antagonists or selective β2AR agonists using the University Groningen IADB.nl prescription database (study period 1994–2019). For each exposed cohort, two reference cohorts (A and B) were matched on age at index date. The main outcome was defined as at least two prescriptions for cholinesterase inhibitors (rivastigmine, galantamine, and donepezil) and/or memantine. Cox proportional hazard regression models were used to estimate hazard ratios (HR). Results: The risk of developing AD was elevated among patients exposed to non-selective βAR antagonists (A: aHR 3.303, 95% CI 1.230–8.869, B: aHR 1.569, 95% CI 0.560–4.394) and reduced among patients exposed to selective β2AR agonists (A: aHR 0.049, 95% CI 0.003–0.795, B: aHR 0.834, 95% CI 0.075–9.273) compared to reference patients. Conclusion: These findings suggest that exposure to non-selective βAR antagonists is associated with an increased risk for developing AD whereas there may be a decreased risk for developing AD after exposure to selective β2AR agonists.Keywords
This publication has 34 references indexed in Scilit:
- Stimulation of central β2-adrenoceptors suppresses NFκB activity in rat brain: A role for IκBNeurochemistry International, 2013
- Propranolol restores cognitive deficits and improves amyloid and Tau pathologies in a senescence-accelerated mouse modelNeuropharmacology, 2013
- Anti-Inflammatory and Antinociceptive Effects of Salbutamol on Acute and Chronic Models of Inflammation in Rats: Involvement of an Antioxidant MechanismMediators of Inflammation, 2012
- Cognitive Function and Antihypertensive Treatment in the Elderly: A 6-Year Follow-up StudyAmerican Journal of Therapeutics, 2010
- Blocking β2-adrenergic receptor attenuates acute stress-induced amyloid β peptides productionBrain Research, 2010
- Effects of Cardiovascular Medications on Rate of Functional Decline in Alzheimer DiseaseThe American Journal of Geriatric Psychiatry, 2008
- Activation of β2-adrenergic receptor stimulates γ-secretase activity and accelerates amyloid plaque formationNature Medicine, 2006
- β‐Site APP cleaving enzyme up‐regulation induced by 4‐hydroxynonenal is mediated by stress‐activated protein kinases pathwaysJournal of Neurochemistry, 2005
- Expression of human β‐secretase in the mouse brain increases the steady‐state level of β‐amyloidJournal of Neurochemistry, 2002
- Inflammatory Response in Alzheimer's Disease.The Tohoku Journal of Experimental Medicine, 1994